Identification of microRNAs and mRNAs associated with multidrug resistance of human laryngeal cancer hep-2 cells

Brazilian Journal of Medical and Biological Research

Volumn 46, Issue 6, 2013, Pages 546-554

  Yin, Wanzhong ^a   Wang, Ping ^a   Wang, Xin ^a   Song, Wenzhi ^b   Cui, Xiangyan ^a   Yu, Hong ^a   Zhu, Wei ^a  

^a Basic Medical College   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Hep 2 cells; Laryngeal cancer; Microrna; Mrna; Multidrug resistance

Indexed keywords

CISPLATIN; ENZYME ACTIVATOR; FLUOROURACIL; MESSENGER RNA; MICRORNA; MICRORNA 210; MULTIDRUG RESISTANCE PROTEIN 1; NUCLEAR PROTEIN; RHODAMINE 123; VINCRISTINE;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LARYNX CANCER; MICROARRAY ANALYSIS; MULTIDRUG RESISTANCE; PHENOTYPE; PREDICTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUOROURACIL; G1 PHASE CELL CYCLE CHECKPOINTS; GENES, MDR; HUMANS; LARYNGEAL NEOPLASMS; MICRORNAS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RGS PROTEINS; RHODAMINE 123; RNA, MESSENGER; SERINE ENDOPEPTIDASES; TISSUE ARRAY ANALYSIS; VINCRISTINE;

EID: 84880387482     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20131662     Document Type: Article

References (35)

1. Carew JF, Shah JP. Advances in multimodality therapy for laryngeal cancer. CA Cancer J Clin 1998; 48: 211-228 doi: 10.3322/canjclin.48.4.211.
2. Bier H. Chemotherapeutic drug resistance in the management of head and neck cancer. Eur Arch Otorhinolaryngol 1993; 250: 200-208 doi: 10.1007/BF00171524.
3. Stavrovskaya AA. Cellular mechanisms of multidrug resistance of tumor cells. Biochemistry 2000; 65: 95-106.
4. Laberge RM, Karwatsky J, Lincoln MC, Leimanis ML, Georges E. Modulation of GSH levels in ABCC1 expressing tumor cells triggers apoptosis through oxidative stress. Biochem Pharmacol 2007; 73: 1727-1737 doi: 10.1016/ j.bcp.2007.02.005.
5. Higgins CF. Multiple molecular mechanisms for multidrug resistance transporters. Nature 2007; 446: 749-757 doi: 10.1038/nature05630.
6. Estrela JM, Ortega A, Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 2006; 43: 143-181. doi: 10.1080/10408360500523878.
7. Kang MR, Chung IK. Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine. Mol Pharmacol 2002; 61: 879-884. doi: 10.1124/mol.61.4.879.
8. Keshelava N, Zuo JJ, Chen P, Waidyaratne SN, Luna MC, Gomer CJ, et al. Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res 2001; 61: 6185-6193.
9. Brozovic A, Majhen D, Roje V, Mikac N, Jakopec S, Fritz G, et al. Alpha(v)beta(3) integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione- dependent elimination of drug-induced reactive oxidative species. Mol Pharmacol 2008; 74: 298-306 doi: 10.1124/mol.107.043836.
10. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297, doi: 10.1016/S0092-8674(04)00045-5
11. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355 doi: 10.1038/nature02871.
12. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006; 66: 7390-7394 doi: 10.1158/0008-5472.CAN-06-0800.
13. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006; 25: 6188-6196 doi: 10.1038/sj.onc. 1209913.
14. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838 doi: 10.1038/nature03702.
15. Climent J, Dimitrow P, Fridlyand J, Palacios J, Siebert R, Albertson DG, et al. Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer. Cancer Res 2007; 67: 818-826 doi: 10.1158/ 0008-5472.CAN-06-3307.
16. Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemother- apeutic drug doxorubicin. Mol Cancer Ther 2008; 7: 2152-2159 doi: 10.1158/1535-7163.MCT-08-0021.
17. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008; 123: 372-379 doi: 10.1002/ijc.23501.
18. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resis- tance by targeting PTEN. Cancer Res 2008; 68: 425-433 doi: 10.1158/0008-5472.CAN-07-2488.
19. Fujita Y, Kojima K, Ohhashi R, Hamada N, Nozawa Y, Kitamoto A, et al. MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J Biol Chem 2010; 285: 19076-19084 doi: 10.1074/jbc.M109.079525.
20. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, et al. Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008; 76: 582-588 doi: 10.1016/ j.bcp.2008.06.007.
21. Yang YX, Xiao ZQ, Chen ZC, Zhang GY, Yi H, Zhang PF, et al. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics 2006; 6: 2009-2021 doi: 10.1002/pmic.200402031.
22. Hong L, Wang J, Han Y, Zhao Y, Gao J, Wang J, et al. Reversal of multidrug resistance of vincristine-resistant gastric adenocarcinoma cells through up-regulation of DARPP-32. Cell Biol Int 2007; 31: 1010-1015 doi: 10.1016/ j.cellbi.2007.03.020.
23. Du B, Zhang Y, Tang Y, Wang P. Minocycline attenuates ototoxicity and enhances antitumor activity of cisplatin treatment in vitro. Otolaryngol Head Neck Surg 2011; 144: 719-725 doi: 10.1177/0194599810395090.
24. Hong L, Zhao Y, Wang J, Han Y, Guo W, Jin H, et al. Reversal of multidrug resistance of adriamycin-resistant gastric adenocarcinoma cells through the up-regulation of DARPP-32. Dig Dis Sci 2008; 53: 101-107 doi: 10.1007/ s10620-007-9829-x.
25. Isaacs JT. Relationship between tumor size and curability of prostatic cancer by combined chemo-hormonal therapy in rats. Cancer Res 1989; 49: 6290-6294.
26. Blower PE, Chung JH, Verducci JS, Lin S, Park JK, Dai Z, et al. MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 2008; 7: 1-9 doi: 10.1158/1535-7163.
27. Mathew LK, Simon MC. Mir-210: a sensor for hypoxic stress during tumorigenesis. Mol Cell 2009; 35: 737-738, doi: 10.1016/j.molcel.2009.09.008.
28. Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, Betts G, et al. Hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010; 116: 2148-2158.
29. Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y, et al. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem 2010; 285: 21496-21507 doi: 10.1074/jbc.M109.083337.
30. Cui XY, Guo YJ, Yao HR. [Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR]. Nan Fang Yi Ke Da Xue Xue Bao 2008; 28: 1813-1815.
31. Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, et al. Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity. J Clin Invest 2006; 116: 1994-2004 doi: 10.1172/JCI27698.
32. Clark DW, Mitra A, Fillmore RA, Jiang WG, Samant RS, Fodstad O, et al. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress. Curr Cancer Drug Targets 2008; 8: 421-430, doi: 10.2174/156800908785133196.
33. Chowdhury UR, Samant RS, Fodstad O, Shevde LA. Emerging role of nuclear protein 1 (NUPR1) in cancer biology. Cancer Metastasis Rev 2009; 28: 225-232 doi: 10.1007/s10555-009-9183-x.
34. Ito Y, Yoshida H, Motoo Y, Iovanna JL, Nakamura Y, Kakudo K, et al. Expression of p8 protein in breast carcinoma: an inverse relationship with apoptosis. Anticancer Res 2005; 25: 833-837.
35. Su SB, Motoo Y, Iovanna JL, Berthezene P, Xie MJ, Mouri H, et al. Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer. Clin Cancer Res 2001; 7: 1320-1324.